These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1400342)

  • 1. Endothelial monocyte-activating polypeptide II. A novel tumor-derived polypeptide that activates host-response mechanisms.
    Kao J; Ryan J; Brett G; Chen J; Shen H; Fan YG; Godman G; Familletti PC; Wang F; Pan YC
    J Biol Chem; 1992 Oct; 267(28):20239-47. PubMed ID: 1400342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a novel tumor-derived cytokine. Endothelial-monocyte activating polypeptide II.
    Kao J; Houck K; Fan Y; Haehnel I; Libutti SK; Kayton ML; Grikscheit T; Chabot J; Nowygrod R; Greenberg S
    J Biol Chem; 1994 Oct; 269(40):25106-19. PubMed ID: 7929199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A peptide derived from the amino terminus of endothelial-monocyte-activating polypeptide II modulates mononuclear and polymorphonuclear leukocyte functions, defines an apparently novel cellular interaction site, and induces an acute inflammatory response.
    Kao J; Fan YG; Haehnel I; Brett J; Greenberg S; Clauss M; Kayton M; Houck K; Kisiel W; Seljelid R
    J Biol Chem; 1994 Apr; 269(13):9774-82. PubMed ID: 7545917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A polypeptide factor produced by fibrosarcoma cells that induces endothelial tissue factor and enhances the procoagulant response to tumor necrosis factor/cachectin.
    Clauss M; Murray JC; Vianna M; de Waal R; Thurston G; Nawroth P; Gerlach H; Bach R; Familletti PC; Stern D
    J Biol Chem; 1990 Apr; 265(12):7078-83. PubMed ID: 2324115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial-monocyte-activating polypeptide II.
    Tas MP; Murray JC
    Int J Biochem Cell Biol; 1996 Aug; 28(8):837-41. PubMed ID: 8811833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration.
    Clauss M; Gerlach M; Gerlach H; Brett J; Wang F; Familletti PC; Pan YC; Olander JV; Connolly DT; Stern D
    J Exp Med; 1990 Dec; 172(6):1535-45. PubMed ID: 2258694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial monocyte activating polypeptide II (EMAP II) enhances the effect of TNF on tumor-associated vasculature.
    Kayton ML; Libutti SK
    Curr Opin Investig Drugs; 2001 Jan; 2(1):136-8. PubMed ID: 11527006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of Meth A fibrosarcoma derived EMAP II on dendritic cell migration.
    Haridas S; Bowers M; Tusano J; Mehojah J; Kirkpatrick M; Burnham DK
    Cytokine; 2008 Nov; 44(2):304-9. PubMed ID: 18951814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour necrosis factor receptor I (p55) is upregulated on endothelial cells by exposure to the tumour-derived cytokine endothelial monocyte- activating polypeptide II (EMAP-II).
    Berger AC; Alexander HR; Wu PC; Tang G; Gnant MF; Mixon A; Turner ES; Libutti SK
    Cytokine; 2000 Jul; 12(7):992-1000. PubMed ID: 10880244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial-monocyte activating polypeptide II, a novel antitumor cytokine that suppresses primary and metastatic tumor growth and induces apoptosis in growing endothelial cells.
    Schwarz MA; Kandel J; Brett J; Li J; Hayward J; Schwarz RE; Chappey O; Wautier JL; Chabot J; Lo Gerfo P; Stern D
    J Exp Med; 1999 Aug; 190(3):341-54. PubMed ID: 10430623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitization of tumor necrosis factor alpha-resistant human melanoma by tumor-specific in vivo transfer of the gene encoding endothelial monocyte-activating polypeptide II using recombinant vaccinia virus.
    Gnant MF; Berger AC; Huang J; Puhlmann M; Wu PC; Merino MJ; Bartlett DL; Alexander HR; Libutti SK
    Cancer Res; 1999 Sep; 59(18):4668-74. PubMed ID: 10493523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal cancer cells induce lymphocyte apoptosis by an endothelial monocyte-activating polypeptide-II-dependent mechanism.
    Murray JC; Symonds P; Ward W; Huggins M; Tiga A; Rice K; Heng YM; Todd I; Robins RA
    J Immunol; 2004 Jan; 172(1):274-81. PubMed ID: 14688335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization of endothelial-monocyte-activating polypeptide II (EMAP II), a novel proinflammatory cytokine, to lesions of experimental autoimmune encephalomyelitis, neuritis and uveitis: expression by monocytes and activated microglial cells.
    Schluesener HJ; Seid K; Zhao Y; Meyermann R
    Glia; 1997 Aug; 20(4):365-72. PubMed ID: 9262239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial monocyte activating polypeptide II induces endothelial cell apoptosis and may inhibit tumor angiogenesis.
    Berger AC; Alexander HR; Tang G; Wu PS; Hewitt SM; Turner E; Kruger E; Figg WD; Grove A; Kohn E; Stern D; Libutti SK
    Microvasc Res; 2000 Jul; 60(1):70-80. PubMed ID: 10873516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of EMAP II by hypoxia.
    Matschurat S; Knies UE; Person V; Fink L; Stoelcker B; Ebenebe C; Behrensdorf HA; Schaper J; Clauss M
    Am J Pathol; 2003 Jan; 162(1):93-103. PubMed ID: 12507893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-Dose Endothelial Monocyte-Activating Polypeptide-II Increases Blood-Tumor Barrier Permeability by Activating the RhoA/ROCK/PI3K Signaling Pathway.
    Li Z; Liu XB; Liu YH; Xue YX; Liu J; Teng H; Xi Z; Yao YL
    J Mol Neurosci; 2016 Jun; 59(2):193-202. PubMed ID: 26521255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical analysis of endothelial-monocyte-activating polypeptide-II expression in vivo.
    Murray JC; Barnett G; Tas M; Jakobsen A; Brown J; Powe D; Clelland C
    Am J Pathol; 2000 Dec; 157(6):2045-53. PubMed ID: 11106577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-Dose Endothelial Monocyte-Activating Polypeptide-II Induces Blood-Tumor Barrier Opening Via the cAMP/PKA/Rac1 Pathway.
    Li Z; Liu XB; Liu YH; Xue YX; Liu J; Teng H; Xi Z; Yao YL
    J Mol Neurosci; 2016 Feb; 58(2):153-61. PubMed ID: 26358039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of the C-terminal domain of p43 and the alpha subunit of ATP synthase. Its functional implication in endothelial cell proliferation.
    Chang SY; Park SG; Kim S; Kang CY
    J Biol Chem; 2002 Mar; 277(10):8388-94. PubMed ID: 11741979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EMAP-II expression is associated with macrophage accumulation in primary uveal melanoma.
    Clarijs R; Schalkwijk L; Ruiter DJ; de Waal RM
    Invest Ophthalmol Vis Sci; 2003 May; 44(5):1801-6. PubMed ID: 12714608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.